1
|
Donnelley M, Cmielewski P, Morgan K, Delhove J, Reyne N, McCarron A, Rout-Pitt N, Drysdale V, Carpentieri C, Spiers K, Takeuchi A, Uesugi K, Yagi N, Parsons D. Improved in-vivo airway gene transfer via magnetic-guidance, with protocol development informed by synchrotron imaging. Sci Rep 2022; 12:9000. [PMID: 35637239 PMCID: PMC9151774 DOI: 10.1038/s41598-022-12895-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2022] [Accepted: 05/11/2022] [Indexed: 11/24/2022] Open
Abstract
Gene vectors to treat cystic fibrosis lung disease should be targeted to the conducting airways, as peripheral lung transduction does not offer therapeutic benefit. Viral transduction efficiency is directly related to the vector residence time. However, delivered fluids such as gene vectors naturally spread to the alveoli during inspiration, and therapeutic particles of any form are rapidly cleared via mucociliary transit. Extending gene vector residence time within the conducting airways is important, but hard to achieve. Gene vector conjugated magnetic particles that can be guided to the conducting airway surfaces could improve regional targeting. Due to the challenges of in-vivo visualisation, the behaviour of such small magnetic particles on the airway surface in the presence of an applied magnetic field is poorly understood. The aim of this study was to use synchrotron imaging to visualise the in-vivo motion of a range of magnetic particles in the trachea of anaesthetised rats to examine the dynamics and patterns of individual and bulk particle behaviour in-vivo. We also then assessed whether lentiviral-magnetic particle delivery in the presence of a magnetic field increases transduction efficiency in the rat trachea. Synchrotron X-ray imaging revealed the behaviour of magnetic particles in stationary and moving magnetic fields, both in-vitro and in-vivo. Particles could not easily be dragged along the live airway surface with the magnet, but during delivery deposition was focussed within the field of view where the magnetic field was the strongest. Transduction efficiency was also improved six-fold when the lentiviral-magnetic particles were delivered in the presence of a magnetic field. Together these results show that lentiviral-magnetic particles and magnetic fields may be a valuable approach for improving gene vector targeting and increasing transduction levels in the conducting airways in-vivo.
Collapse
|
2
|
Dubsky S. Synchrotron-Based Dynamic Lung Imaging. Mol Imaging 2021. [DOI: 10.1016/b978-0-12-816386-3.00014-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
3
|
Yang L, Gradl R, Dierolf M, Möller W, Kutschke D, Feuchtinger A, Hehn L, Donnelley M, Günther B, Achterhold K, Walch A, Stoeger T, Razansky D, Pfeiffer F, Morgan KS, Schmid O. Multimodal Precision Imaging of Pulmonary Nanoparticle Delivery in Mice: Dynamics of Application, Spatial Distribution, and Dosimetry. SMALL (WEINHEIM AN DER BERGSTRASSE, GERMANY) 2019; 15:e1904112. [PMID: 31639283 DOI: 10.1002/smll.201904112] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/27/2019] [Revised: 09/12/2019] [Indexed: 06/10/2023]
Abstract
Targeted delivery of nanomedicine/nanoparticles (NM/NPs) to the site of disease (e.g., the tumor or lung injury) is of vital importance for improved therapeutic efficacy. Multimodal imaging platforms provide powerful tools for monitoring delivery and tissue distribution of drugs and NM/NPs. This study introduces a preclinical imaging platform combining X-ray (two modes) and fluorescence imaging (three modes) techniques for time-resolved in vivo and spatially resolved ex vivo visualization of mouse lungs during pulmonary NP delivery. Liquid mixtures of iodine (contrast agent for X-ray) and/or (nano)particles (X-ray absorbing and/or fluorescent) are delivered to different regions of the lung via intratracheal instillation, nasal aspiration, and ventilator-assisted aerosol inhalation. It is demonstrated that in vivo propagation-based phase-contrast X-ray imaging elucidates the dynamic process of pulmonary NP delivery, while ex vivo fluorescence imaging (e.g., tissue-cleared light sheet fluorescence microscopy) reveals the quantitative 3D drug/particle distribution throughout the entire lung with cellular resolution. The novel and complementary information from this imaging platform unveils the dynamics and mechanisms of pulmonary NM/NP delivery and deposition for each of the delivery routes, which provides guidance on optimizing pulmonary delivery techniques and novel-designed NM for targeting and efficacy.
Collapse
Affiliation(s)
- Lin Yang
- Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL), Munich, 81377, Germany
- Institute of Lung Biology and Disease, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, 85764, Germany
- Faculty of Medicine, Technical University of Munich, Munich, 80333, Germany
| | - Regine Gradl
- Chair of Biomedical Physics, Department of Physics, Technical University of Munich, Garching, 85748, Germany
- Munich School of BioEngineering, Technical University of Munich, Garching, 85748, Germany
- Institute for Advanced Study, Technical University of Munich, Garching, 85748, Germany
| | - Martin Dierolf
- Chair of Biomedical Physics, Department of Physics, Technical University of Munich, Garching, 85748, Germany
- Munich School of BioEngineering, Technical University of Munich, Garching, 85748, Germany
| | - Winfried Möller
- Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL), Munich, 81377, Germany
- Institute of Lung Biology and Disease, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, 85764, Germany
| | - David Kutschke
- Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL), Munich, 81377, Germany
- Institute of Lung Biology and Disease, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, 85764, Germany
| | - Annette Feuchtinger
- Research Unit Analytical Pathology, Helmholtz Zentrum München, Neuherberg, 85764, Germany
| | - Lorenz Hehn
- Chair of Biomedical Physics, Department of Physics, Technical University of Munich, Garching, 85748, Germany
- Department of Diagnostic and Interventional Radiology, Klinikum rechts der Isar, Technical University of Munich, München, 81675, Germany
| | - Martin Donnelley
- Robinson Research Institute and Adelaide Medical School, University of Adelaide, Adelaide, 5000, Australia
- Respiratory and Sleep Medicine, Women's and Children's Hospital, North Adelaide, SA, 5006, Australia
| | - Benedikt Günther
- Chair of Biomedical Physics, Department of Physics, Technical University of Munich, Garching, 85748, Germany
- Munich School of BioEngineering, Technical University of Munich, Garching, 85748, Germany
| | - Klaus Achterhold
- Chair of Biomedical Physics, Department of Physics, Technical University of Munich, Garching, 85748, Germany
- Munich School of BioEngineering, Technical University of Munich, Garching, 85748, Germany
| | - Axel Walch
- Research Unit Analytical Pathology, Helmholtz Zentrum München, Neuherberg, 85764, Germany
| | - Tobias Stoeger
- Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL), Munich, 81377, Germany
- Institute of Lung Biology and Disease, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, 85764, Germany
| | - Daniel Razansky
- Faculty of Medicine, Technical University of Munich, Munich, 80333, Germany
- Institute for Biological and Medical Imaging (IBMI), Helmholtz Zentrum München, Neuherberg, 85764, Germany
- Faculty of Medicine and Institute of Pharmacology and Toxicology, University of Zurich, Zurich, CH-8057, Switzerland
- Institute for Biomedical Engineering and Department of Information Technology and Electrical Engineering, ETH Zurich, Zurich, 8093, Switzerland
| | - Franz Pfeiffer
- Chair of Biomedical Physics, Department of Physics, Technical University of Munich, Garching, 85748, Germany
- Munich School of BioEngineering, Technical University of Munich, Garching, 85748, Germany
- Institute for Advanced Study, Technical University of Munich, Garching, 85748, Germany
- Department of Diagnostic and Interventional Radiology, Klinikum rechts der Isar, Technical University of Munich, München, 81675, Germany
| | - Kaye S Morgan
- Chair of Biomedical Physics, Department of Physics, Technical University of Munich, Garching, 85748, Germany
- Institute for Advanced Study, Technical University of Munich, Garching, 85748, Germany
- School of Physics and Astronomy, Monash University, Clayton, Victoria, 3800, Australia
| | - Otmar Schmid
- Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL), Munich, 81377, Germany
- Institute of Lung Biology and Disease, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, 85764, Germany
| |
Collapse
|
4
|
Gradl R, Dierolf M, Yang L, Hehn L, Günther B, Möller W, Kutschke D, Stoeger T, Gleich B, Achterhold K, Donnelley M, Pfeiffer F, Schmid O, Morgan KS. Visualizing treatment delivery and deposition in mouse lungs using in vivo x-ray imaging. J Control Release 2019; 307:282-291. [DOI: 10.1016/j.jconrel.2019.06.035] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2019] [Revised: 06/18/2019] [Accepted: 06/25/2019] [Indexed: 01/17/2023]
|
5
|
Donnelley M, Parsons DW. Gene Therapy for Cystic Fibrosis Lung Disease: Overcoming the Barriers to Translation to the Clinic. Front Pharmacol 2018; 9:1381. [PMID: 30538635 PMCID: PMC6277470 DOI: 10.3389/fphar.2018.01381] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2018] [Accepted: 11/09/2018] [Indexed: 11/19/2022] Open
Abstract
Cystic fibrosis (CF) is a progressive, chronic and debilitating genetic disease caused by mutations in the CF Transmembrane-Conductance Regulator (CFTR) gene. Unrelenting airway disease begins in infancy and produces a steady deterioration in quality of life, ultimately leading to premature death. While life expectancy has improved, current treatments for CF are neither preventive nor curative. Since the discovery of CFTR the vision of correcting the underlying genetic defect - not just treating the symptoms - has been developed to where it is poised to become a transformative technology. Addition of a properly functioning CFTR gene into defective airway cells is the only biologically rational way to prevent or treat CF airway disease for all CFTR mutation classes. While new gene editing approaches hold exciting promise, airway gene-addition therapy remains the most encouraging therapeutic approach for CF. However, early work has not yet progressed to large-scale clinical trials. For clinical trials to begin in earnest the field must demonstrate that gene therapies are safe in CF lungs; can provide clear health benefits and alter the course of lung disease; can be repeatedly dosed to boost effect; and can be scaled effectively from small animal models into human-sized lungs. Demonstrating the durability of these effects demands relevant CF animal models and accurate and reliable techniques to measure benefit. In this review, illustrated with data from our own studies, we outline recent technological developments and discuss these key questions that we believe must be answered to progress CF airway gene-addition therapies to clinical trials.
Collapse
Affiliation(s)
- Martin Donnelley
- Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia
- Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia
- Respiratory and Sleep Medicine, Women’s and Children’s Hospital, North Adelaide, SA, Australia
| | - David W. Parsons
- Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia
- Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia
- Respiratory and Sleep Medicine, Women’s and Children’s Hospital, North Adelaide, SA, Australia
| |
Collapse
|
6
|
In vivo Dynamic Phase-Contrast X-ray Imaging using a Compact Light Source. Sci Rep 2018; 8:6788. [PMID: 29717143 PMCID: PMC5931574 DOI: 10.1038/s41598-018-24763-8] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2017] [Accepted: 04/05/2018] [Indexed: 12/14/2022] Open
Abstract
We describe the first dynamic and the first in vivo X-ray imaging studies successfully performed at a laser-undulator-based compact synchrotron light source. The X-ray properties of this source enable time-sequence propagation-based X-ray phase-contrast imaging. We focus here on non-invasive imaging for respiratory treatment development and physiological understanding. In small animals, we capture the regional delivery of respiratory treatment, and two measures of respiratory health that can reveal the effectiveness of a treatment; lung motion and mucociliary clearance. The results demonstrate the ability of this set-up to perform laboratory-based dynamic imaging, specifically in small animal models, and with the possibility of longitudinal studies.
Collapse
|
7
|
Cmielewski P, Farrow N, Devereux S, Parsons D, Donnelley M. Gene therapy for Cystic Fibrosis: Improved delivery techniques and conditioning with lysophosphatidylcholine enhance lentiviral gene transfer in mouse lung airways. Exp Lung Res 2017; 43:426-433. [PMID: 29236544 DOI: 10.1080/01902148.2017.1395931] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
Purpose/Aim: Cystic fibrosis (CF) is the most common, fatal recessive genetic disease among the Caucasian population. Gene therapy has the potential to treat CF long term, however physiological barriers can prevent VSV-G pseudotyped lentiviral (LV) vectors from efficiently accessing the relevant receptors on the basolateral membrane of airway epithelial cells. The aims of this experiment were to use our new dose delivery techniques to determine whether conditioning the mouse lung conducting airways with lysophosphatidylcholine (LPC) improves the level of airway gene expression. MATERIALS AND METHODS Anaesthetised normal C57Bl/6 mice were intubated with an endotracheal cannula to non-invasively facilitate airway access. The airways were conditioned with 0.1% LPC, 0.3% LPC, or PBS (control) instilled via the ET tube. One hour later a VSV-G pseudotyped LV vector carrying the LacZ transgene was delivered. LacZ expression was measured by X-gal staining of the excised lungs 3 months after gene delivery. RESULTS Endotracheal intubation enabled precise dose delivery to the trachea and conducting airways. The cartilaginous airways of the groups conditioned with 0.1% and 0.3% LPC contained significantly larger numbers of LacZ positive cells compared to the PBS control group. In the LPC conditioned groups the majority of cell transduction was in ciliated epithelial cells. CONCLUSION LPC conditioning prior to LV vector delivery, substantially enhanced the level of conducting airway gene expression after a single gene vector delivery. These results extend the previously established effectiveness of this protocol for producing gene expression in the nasal airways to the lung airways, the primary site of deleterious pathophysiology in CF individuals.
Collapse
Affiliation(s)
- Patricia Cmielewski
- a Department of Respiratory and Sleep Medicine , Women's and Children's Hospital Network , North Adelaide , SA , Australia.,b Robinson Research Institute, University of Adelaide , Adelaide , SA , Australia.,c Discipline of Paediatrics, Adelaide Medical School, Faculty of Health and Medical Sciences , University of Adelaide , Adelaide , SA , Australia
| | - Nigel Farrow
- a Department of Respiratory and Sleep Medicine , Women's and Children's Hospital Network , North Adelaide , SA , Australia.,b Robinson Research Institute, University of Adelaide , Adelaide , SA , Australia.,c Discipline of Paediatrics, Adelaide Medical School, Faculty of Health and Medical Sciences , University of Adelaide , Adelaide , SA , Australia
| | - Sharnna Devereux
- c Discipline of Paediatrics, Adelaide Medical School, Faculty of Health and Medical Sciences , University of Adelaide , Adelaide , SA , Australia
| | - David Parsons
- a Department of Respiratory and Sleep Medicine , Women's and Children's Hospital Network , North Adelaide , SA , Australia.,b Robinson Research Institute, University of Adelaide , Adelaide , SA , Australia.,c Discipline of Paediatrics, Adelaide Medical School, Faculty of Health and Medical Sciences , University of Adelaide , Adelaide , SA , Australia
| | - Martin Donnelley
- a Department of Respiratory and Sleep Medicine , Women's and Children's Hospital Network , North Adelaide , SA , Australia.,b Robinson Research Institute, University of Adelaide , Adelaide , SA , Australia.,c Discipline of Paediatrics, Adelaide Medical School, Faculty of Health and Medical Sciences , University of Adelaide , Adelaide , SA , Australia
| |
Collapse
|
8
|
Cmielewski P, Donnelley M, Parsons DW. Long-term therapeutic and reporter gene expression in lentiviral vector treated cystic fibrosis mice. J Gene Med 2015; 16:291-9. [PMID: 25130650 DOI: 10.1002/jgm.2778] [Citation(s) in RCA: 36] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2014] [Revised: 08/01/2014] [Accepted: 08/05/2014] [Indexed: 12/22/2022] Open
Abstract
BACKGROUND Persistent reporter gene and cystic fibrosis transmembrane conductance regulator (CFTR) nasal airway gene expression can be achieved with a single lentiviral (LV) gene vector dosing when coupled with a preparatory lysophosphatidylcholine (LPC) airway pre-treatment. In the present study, we characterised the duration of gene expression in individual cystic fibrosis (CF) knockout mice (cftr(tm1unc)) over their lifetimes. METHODS CF mouse nasal airways were treated with LV-Rx, a mixture of a therapeutic LV-CFTR gene vector and a LV-luciferase reporter gene vector, after pre-treatment with LPC. Control groups received either PBS sham pre-treatment followed by LV-Rx, or LPC prior to delivery of a LV vector containing no transgene (LV-MT). Airway reporter gene expression was monitored by bioluminescence, and functional CFTR expression was assessed via nasal transepithelial potential difference measurements at regular intervals up to 21 months. The presence of the CFTR transgene in the nasal septa, liver and spleen tissues were assessed by a quantitative polymerase chain reaction. Circulating antibodies to the vector glycoprotein envelope and to the luciferase protein were also measured. RESULTS The combined use of LPC and LV gene vectors in the nasal airway produced enhanced and sustained luciferase and CFTR gene expression lasting at least 12 months. Improved survival was also observed in CF knockout mice treated with the LV vector mixture compared to all control CF mouse groups. CONCLUSIONS The present study showed that our airway pre-treatment and gene delivery technique resulted in sustained functional CFTR expression and improved survival in CF mice.
Collapse
Affiliation(s)
- Patricia Cmielewski
- Respiratory and Sleep Medicine, Women's and Children's Hospital Network, North Adelaide, SA, Australia; School of Paediatrics and Reproductive Health, University of Adelaide, Adelaide, SA, Australia; Robinson Research Institute and Centre for Stem Cell Research, University of Adelaide, Adelaide, SA, Australia
| | | | | |
Collapse
|
9
|
Cmielewski P, Farrow N, Donnelley M, McIntyre C, Penny-Dimri J, Kuchel T, Parsons D. Transduction of ferret airway epithelia using a pre-treatment and lentiviral gene vector. BMC Pulm Med 2014; 14:183. [PMID: 25413892 PMCID: PMC4258949 DOI: 10.1186/1471-2466-14-183] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2014] [Accepted: 11/10/2014] [Indexed: 01/31/2023] Open
Abstract
Background The safety and efficiency of gene therapies for cystic fibrosis (CF) need to be assessed in pre-clinical models. Using the normal ferret, this study sought to determine whether ferret airway epithelia could be transduced with a lysophosphatidylcholine (LPC) pre-treatment followed by a VSV-G pseudotyped HIV-1 based lentiviral (LV) vector, in preparation for future studies in CF ferrets. Methods Six normal ferrets (7 -8 weeks old) were treated with a 150 μL LPC pre-treatment, followed one hour later by a 500 μL LV vector dose containing the LacZ transgene. LacZ gene expression in the conducting airways and lung was assessed by X-gal staining after 7 days. The presence of transduction in the lung, as well as off-target transduction in the liver, spleen and gonads, were assessed by qPCR. The levels of LV vector p24 protein bio-distribution in blood sera were assessed by ELISA at 0, 1, 3, 5 and 7 days. Results The dosing protocol was well tolerated. LacZ gene expression was observed en face in the trachea of all animals. Histology showed that ciliated and basal cells were transduced in the trachea, with rare LacZ transduced single cells noted in lung. p24 levels was not detectable in the sera of 5 of the 6 animals. The LacZ gene was not detected in the lung tissue and no off-target transduction was detected by qPCR. Conclusions This study shows that ferret airway epithelia are transducible using our unique two-step pre-treatment and LV vector dosing protocol. We have identified a number of unusual anatomical factors that are likely to influence the level of transduction that can be achieved in ferret airways. The ability to transduce ferret airway epithelium is a promising step towards therapeutic LV-CFTR testing in a CF ferret model.
Collapse
Affiliation(s)
- Patricia Cmielewski
- Respiratory and Sleep Medicine, Women's and Children's Hospital, 72 King William Road, North Adelaide, SA 5006, Australia.
| | | | | | | | | | | | | |
Collapse
|
10
|
Hu DD, Chen Y, Bihi A, Li XM, Wang TL, Wang BE, Zhao XY. A new conversation between radiology and pathology-identifying microvascular architecture in stages of cirrhosis via diffraction enhanced imaging in vitro. PLoS One 2014; 9:e87957. [PMID: 24504507 PMCID: PMC3913676 DOI: 10.1371/journal.pone.0087957] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2013] [Accepted: 01/06/2014] [Indexed: 12/18/2022] Open
Abstract
Background/Aim Diffraction enhanced imaging (DEI) is a synchrotron radiation X-ray phase-contrast imaging technique that can better reveal the microstructure of biological soft tissues than conventional X-rays. The aim of this study is to investigate the angio-architectural changes of the liver during fibrosis, cirrhosis and its subsequent regression by applying synchrotron radiation based DEI. Methods DEI experiments were performed at the 4W1A station of Beijing Synchrotron Radiation Facility. Twenty-four Sprague-Dawley rats were induced with liver fibrosis by carbon tetrachloride (CCl4) for up to 10 weeks, after which spontaneous regression started and continued until week 30. Quantitative analysis of the DEI images yielded the mean vascular density and intercapillary distance, which was then re-confirmed by immunohistochemical analysis of CD34. Results Based on the DEI results, the mean vascular density was 1.4-fold higher in fibrotic rats (at week 6) and 2-fold higher in cirrhotic rats (at week 10) compared with the control (p<0.05). Accordingly, the intercapillary distance decreased to 563.89±243.35 µm in fibrotic rats and 392.90±92.68 µm in cirrhotic rats compared with 673.85±214.16µm in the control (p<0.05). During fibrosis regression at week 30, vascular density was 0.7-fold lower and intercapillary distance increased to 548.60±210.94 µm as compared with cirrhotic rats (p<0.05).In parallel to the DEI results, immunohistochemical analysis of CD34 showed similar changes. Conclusion Synchrotron-based DEI can conduct radiological as well as pathological analysis. Our results are consistent with previous reports indicating that angiogenesis is directly proportional to fibrosis progression. Furthermore, by clarifying the vascular characteristics of liver diseases, DEI reveals that cirrhosis cannot fully reverse during fibrosis regression.
Collapse
Affiliation(s)
- Dou-dou Hu
- Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China
| | - Yu Chen
- Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China
| | - Ali Bihi
- International School of Capital Medical University. Beijing, China
| | - Xin-min Li
- Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China
| | - Tai-ling Wang
- Department of Pathology, China-Japan Friendship Hospital, Beijing, China
| | - Bao-en Wang
- Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China
- * E-mail: (BW); (XZ)
| | - Xin-yan Zhao
- Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China
- * E-mail: (BW); (XZ)
| |
Collapse
|
11
|
Non-invasive airway health assessment: synchrotron imaging reveals effects of rehydrating treatments on mucociliary transit in-vivo. Sci Rep 2014; 4:3689. [PMID: 24418935 PMCID: PMC3891397 DOI: 10.1038/srep03689] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2013] [Accepted: 12/17/2013] [Indexed: 11/27/2022] Open
Abstract
To determine the efficacy of potential cystic fibrosis (CF) therapies we have developed a novel mucociliary transit (MCT) measurement that uses synchrotron phase contrast X-ray imaging (PCXI) to non-invasively measure the transit rate of individual micron-sized particles deposited into the airways of live mice. The aim of this study was to image changes in MCT produced by a rehydrating treatment based on hypertonic saline (HS), a current CF clinical treatment. Live mice received HS containing a long acting epithelial sodium channel blocker (P308); isotonic saline; or no treatment, using a nebuliser integrated within a small-animal ventilator circuit. Marker particle motion was tracked for 20 minutes using PCXI. There were statistically significant increases in MCT in the isotonic and HS-P308 groups. The ability to quantify in vivo changes in MCT may have utility in pre-clinical research studies designed to bring new genetic and pharmaceutical treatments for respiratory diseases into clinical trials.
Collapse
|
12
|
Donnelley M, Morgan KS, Siu KKW, Parsons DW. Variability of in vivo fluid dose distribution in mouse airways is visualized by high-speed synchrotron X-ray imaging. J Aerosol Med Pulm Drug Deliv 2013; 26:307-16. [PMID: 23298238 DOI: 10.1089/jamp.2012.1007] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND The manner in which fluid instillations into mouse nose and lung distribute through the airways is poorly understood. Many agents are delivered in this way for testing as therapeutics, or as challenges designed to establish infections or create systemic drug delivery effects. These agents are delivered into mouse airways with little knowledge of the manner in which doses move through the airways, how long they reside in each region, and where the instilled materials eventually reach. METHODS Synchrotron phase-contrast X-ray imaging (PCXI) was used to elucidate the primary controlling characteristics of mouse airway fluid dosing. High-speed image acquisition was used to track the movement of a range of bolus doses of an iodine-based contrast fluid through the nose (n=15) and lungs (n=10) of live anesthetized mice. For the lung studies, the mice were ventilated and paralyzed to control animal movement. Post-experiment image processing was used to visualize the fluid movement. RESULTS The maximum dose that could be retained in only the anterior nose was ∼7.5 μL (20 g mouse), and a range of dynamic dose behaviors was documented after delivery. In the lung, the use of mechanical ventilation in combination with a paralytic agent prevented confounding artifactual movement, improving visualization of fluid progression through the airways. In the lung, optimized image analysis using the high image capture rate revealed the presence of respiratory pauses that could not be visualized at slower acquisition rates. The variability in the outcome of identical dose deliveries in different animals indicates that uniform lung distribution cannot be expected to occur with tracheal fluid delivery. CONCLUSIONS With adequate imaging rate and fluid dose parameters, this study shows the utility of synchrotron PCXI for determining the post-delivery behavior and fate of fluid doses such as those used in in vivo gene transfer or pharmaceutical studies.
Collapse
Affiliation(s)
- Martin Donnelley
- 1 Respiratory and Sleep Medicine, Women's and Children's Health Network , Adelaide, Australia
| | | | | | | |
Collapse
|
13
|
Bravin A, Coan P, Suortti P. X-ray phase-contrast imaging: from pre-clinical applications towards clinics. Phys Med Biol 2012; 58:R1-35. [PMID: 23220766 DOI: 10.1088/0031-9155/58/1/r1] [Citation(s) in RCA: 379] [Impact Index Per Article: 31.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Phase-contrast x-ray imaging (PCI) is an innovative method that is sensitive to the refraction of the x-rays in matter. PCI is particularly adapted to visualize weakly absorbing details like those often encountered in biology and medicine. In past years, PCI has become one of the most used imaging methods in laboratory and preclinical studies: its unique characteristics allow high contrast 3D visualization of thick and complex samples even at high spatial resolution. Applications have covered a wide range of pathologies and organs, and are more and more often performed in vivo. Several techniques are now available to exploit and visualize the phase-contrast: propagation- and analyzer-based, crystal and grating interferometry and non-interferometric methods like the coded aperture. In this review, covering the last five years, we will give an overview of the main theoretical and experimental developments and of the important steps performed towards the clinical implementation of PCI.
Collapse
Affiliation(s)
- Alberto Bravin
- European Synchrotron Radiation Facility, 6 rue Horowitz, 38043 Grenoble Cedex, France.
| | | | | |
Collapse
|
14
|
Jung JW, Lee JS, Kwon N, Park SJ, Chang S, Kim J, Pyo J, Kohmura Y, Nishino Y, Yamamoto M, Ishikawa T, Je JH. Fast microtomography using bright monochromatic x-rays. THE REVIEW OF SCIENTIFIC INSTRUMENTS 2012; 83:093704. [PMID: 23020380 DOI: 10.1063/1.4751853] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
A fast microtomography system for high-resolution high-speed imaging has been developed using bright monochromatic x-rays at the BL29XU beamline of SPring-8. The shortest scan time for microtomography we attained was 0.25 s in 1.25 μm effective pixel size by combining the bright monochromatic x-rays, a fast rotating sample stage, and a high performance x-ray imaging detector. The feasibility of the tomography system was successfully demonstrated by visualization of rising bubbles in a viscous liquid, an interesting issue in multiphase flow physics. This system also provides a high spatial (a measurable feature size of 300 nm) or a very high temporal (9.8 μs) resolution in radiographs.
Collapse
Affiliation(s)
- J W Jung
- X-ray Imaging Center, Pohang University of Science and Technology, San 31, Hyoja-dong, Pohang 790-784, South Korea
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|